Suppression of anti-malarial humoral immune responses by gamaherpesviruses
伽马疱疹病毒抑制抗疟疾体液免疫反应
基本信息
- 批准号:9444089
- 负责人:
- 金额:$ 39.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-01 至 2021-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffectAffinityAfrica South of the SaharaAgeAlpha CellAnemiaAntibodiesAntibody FormationAntibody ResponseAntibody SpecificityAntigensAntimalarialsB-LymphocytesBloodCapsidCellsCerebral MalariaCessation of lifeChildChildhoodCoinCountryDataDevelopmentDiseaseEpitopesEpstein-Barr Virus InfectionsEventFalciparum MalariaFeverGenetic TranscriptionGoalsHelper-Inducer T-LymphocyteHospitalizationHuman Herpesvirus 4Humoral ImmunitiesImmuneImmune responseImmunityImmunoglobulin MImmunosuppressionImmunosuppressive AgentsImpairmentIncomeInfantInfectionInterleukin-10KnowledgeLaboratoriesLifeLongevityMalariaMemoryMissionMonitorMoralsOutcomeParasitemiaParasitesPlasmodiumPlasmodium falciparumPopulationPrimary InfectionProteinsPublic HealthPublishingResearchRisk FactorsRodent ModelSecondary toTestingUnited States National Institutes of HealthViralVirus DiseasesVirus LatencyWorkantigen challengeclinical developmentco-infectiondisabilityexperiencegammaherpesvirushuman diseaseinfected B cellinnovationinsightlatency-associated proteinmalaria infectionmouse modelnegative affectnovelnovel therapeutic interventionpreventresponseseropositivestem
项目摘要
The humoral response to malaria is critical in the control of blood stage parasitemia and the breadth of
the antibody response is protective against the development of clinical malaria. It is not understood why
some children fail to develop adequate humoral immune responses to Plasmodium infection early in
life. Both Plasmodium falciparum malaria and Epstein Barr virus (EBV) are childhood infections in sub-
Saharan Africa. The majority of children become seropositive for EBV within the first years of life, an
event that is normally asymptomatic but accompanied by potent immunosuppression. The long term
goal of this proposal is to provide mechanistic evidence that overlapping acute gammaherpesvirus coin-
fections are responsible for suppressing the development of humoral immunity during Plasmodium in-
fection in children. Using well established mouse models of EBV (MHV68) and malaria the objective of
this proposal is to identify how the humoral immune response to malaria is altered by an MHV68 la-
tency associated protein (M2), and to identify which features of the humoral response are affected
(magnitude, breadth, affinity and longevity). The central hypothesis of this proposal is that the induction
of IL-10 by M2 in MHV68-infected B cells impairs the ability of T follicular helper cells to provide B cell
help for effective, broad spectrum antibody production to incoming Plasmodium infection. This hypothe-
sis has been formulated from our published and preliminary data showing that M2 induces substantial
amount of IL-10 in B cells and that pre-existing suppression of humoral immunity to Plasmodium by
MHV68 in a primary infection also resulted in an ineffective memory responses upon challenge infec-
tion. The rationale for the proposed work is that the development of new therapeutic strategies to en-
sure protective humoral immunity develops in children depends on an understanding of the contributing
factors that prevent the development of the humoral response in the first place. Guided by strong pre-
liminary data, the central hypothesis will be tested by pursuing 3 specific aims: 1) To determine how the
response of Tfh cells to an incoming Plasmodium infection is altered by M2-induced IL-10 secretion
from MHV68-infected B cells 2) To determine how the breadth, affinity and longevity of the anti-malarial
humoral response is altered by pre-existing gammaherpesvirus infection (3) To demonstrate that hu-
moral immunity to P. falciparum in children is reduced by acute immunosuppressive EBV infection. The
approach is innovative because our proposed research uses novel rodent models of EBV and Plasmo-
dium co-infection and incorporates transcriptional profiling of B cell populations to enable the breadth of
humoral immune responses to malaria to be determined. The proposed research is significant because
it is expected to advance understanding of how the development of immunity to malaria can be ad-
versely impacted by viral co-infections.
对疟疾的体液反应对于控制血期寄生虫和广度至关重要
抗体反应可抵抗临床疟疾的发展。不明白为什么
一些儿童未能在早期对疟原虫感染产生足够的体液免疫反应
生活。恶性疟原虫疟疾和爱泼斯坦巴尔病毒(EBV)都是亚下儿童感染
撒哈拉非洲。大多数儿童在生命的头几年内对EBV的血清反应阳性,这是
通常无症状的事件,但伴随着有效的免疫抑制。长期
该提案的目标是提供机械证据,表明急性伽马病毒硬币重叠
曲线负责抑制疟原虫内体液免疫发展的发展
儿童的饮食。使用良好的EBV的鼠标模型(MHV68)和疟疾的目的
该建议是确定MHV68 LA-的体液免疫反应如何改变
紧密相关的蛋白质(M2),并确定体液反应的哪些特征受到影响
(大小,广度,亲和力和寿命)。该提议的中心假设是归纳
在MHV68感染的B细胞中,M2的IL-10损害T卵泡辅助细胞提供B细胞的能力
帮助有效的广谱抗体产生传入的疟原虫感染。这个假设
SIS是根据我们发布的和初步数据提出的,表明M2诱导了大量
B细胞中IL-10的量以及预先存在对疟原虫的体液免疫的抑制
原发性感染中的MHV68还导致挑战不良的记忆反应无效。
tion。拟议工作的理由是制定新的治疗策略以纳入
确保儿童的保护性体液免疫力取决于对贡献的理解
首先阻止体液反应发展的因素。在强大的前指导
限量数据,中心假设将通过追求3个具体目的来检验:1)确定如何确定如何
M2诱导的IL-10分泌改变了TFH细胞对传入疟原虫感染的反应
从MHV68感染的B细胞2)确定抗疟疾的宽度,亲和力和寿命如何
预先存在的γ掌病毒感染(3)可以改变体液反应(3)
急性免疫抑制EBV感染可降低对儿童恶性疟原虫的道德免疫。这
方法是创新的,因为我们提出的研究使用了EBV和Plasmo-的新型啮齿动物模型
dium共感染并结合了B细胞群体的转录分析,以实现
对要确定疟疾的体液免疫反应。拟议的研究很重要,因为
预计将进一步了解疟疾免疫的发展如何。
受病毒共感染的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tracey Jane Lamb其他文献
Tracey Jane Lamb的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tracey Jane Lamb', 18)}}的其他基金
Genetic and Immunological Control for Development of Asymptomatic Malaria
无症状疟疾发展的遗传和免疫控制
- 批准号:
10260246 - 财政年份:2021
- 资助金额:
$ 39.51万 - 项目类别:
Genetic and Immunological Control for Development of Asymptomatic Malaria
无症状疟疾发展的遗传和免疫控制
- 批准号:
10415195 - 财政年份:2021
- 资助金额:
$ 39.51万 - 项目类别:
Ephrin ligands as novel targets for an adjunct therapy in cerebral malaria
Ephrin配体作为脑型疟疾辅助治疗的新靶点
- 批准号:
8771568 - 财政年份:2014
- 资助金额:
$ 39.51万 - 项目类别:
The development of probiotic yeast as an inexpensive vaccine delivery platform
益生菌酵母作为廉价疫苗输送平台的开发
- 批准号:
8572767 - 财政年份:2013
- 资助金额:
$ 39.51万 - 项目类别:
相似国自然基金
线上民宿房东亲和力对房客预定行为的影响机制研究——基于多源异构数据视角
- 批准号:72202154
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
线上民宿房东亲和力对房客预定行为的影响机制研究——基于多源异构数据视角
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
估计和解释序列变体对蛋白质稳定性、结合亲和力以及功能的影响
- 批准号:31701136
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
RGS19对嗜酸细胞性食管炎FcεRI信号传导通路的影响及其作用机制的研究
- 批准号:81500502
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
人B组腺病毒纤毛蛋白与DSG2受体亲和力的差异及其对病毒致病力的影响研究
- 批准号:31570163
- 批准年份:2015
- 资助金额:62.0 万元
- 项目类别:面上项目
相似海外基金
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
- 批准号:
10817516 - 财政年份:2023
- 资助金额:
$ 39.51万 - 项目类别:
Supplement for Role of Environmental Weathering and Gastrointestinal Digestion on the Bioavailability and Toxicity of Microplastic and Cadmium Mixtures
补充环境风化和胃肠消化对微塑料和镉混合物的生物利用度和毒性的作用
- 批准号:
10854398 - 财政年份:2023
- 资助金额:
$ 39.51万 - 项目类别:
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:
10727268 - 财政年份:2023
- 资助金额:
$ 39.51万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 39.51万 - 项目类别:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
- 批准号:
10683443 - 财政年份:2023
- 资助金额:
$ 39.51万 - 项目类别: